| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antiemetic activity of ondansetron in cancer patients receiving non-cisplatin chemotherapy
|
Fraschini, Giuseppe
|
|
1992
|
19 |
4S10 |
p. 41-47
7 p.
|
artikel
|
| 2 |
Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis
|
Hesketh, Paul J.
|
|
1992
|
19 |
4S10 |
p. 33-40
8 p.
|
artikel
|
| 3 |
Ondansetron: A new concept in the management of emesis: A panel discussion. Part 1
|
|
|
1992
|
19 |
4S10 |
p. 28-32
5 p.
|
artikel
|
| 4 |
Ondansetron: A new concept in the management of emesis: A panel discussion. Part 2
|
|
|
1992
|
19 |
4S10 |
p. 72-78
7 p.
|
artikel
|
| 5 |
Ondansetron metabolism and pharmacokinetics
|
Pritchard, J.Frederick
|
|
1992
|
19 |
4S10 |
p. 9-15
7 p.
|
artikel
|
| 6 |
Pharmacology and preclinical antiemetic properties of ondansetron
|
Tyers, Michael B.
|
|
1992
|
19 |
4S10 |
p. 1-8
8 p.
|
artikel
|
| 7 |
Phase I and other dose-ranging studies of ondansetron
|
Grunberg, Steven M.
|
|
1992
|
19 |
4S10 |
p. 16-22
7 p.
|
artikel
|
| 8 |
Phase II trials of ondansetron with high-dose cisplatin
|
Kris, Mark G.
|
|
1992
|
19 |
4S10 |
p. 23-27
5 p.
|
artikel
|
| 9 |
Rationale for combination antiemetic therapy and strategies for the use of ondansetron in combinations
|
Kris, Mark G.
|
|
1992
|
19 |
4S10 |
p. 61-66
6 p.
|
artikel
|
| 10 |
The delayed-emesis syndrome from cisplatin: Phase III evaluation of ondansetron versus placebo
|
Gandara, David R.
|
|
1992
|
19 |
4S10 |
p. 67-71
5 p.
|
artikel
|
| 11 |
The use of ondansetron in patients receiving multiple-day cisplatin regimens
|
Hainsworth, John D.
|
|
1992
|
19 |
4S10 |
p. 48-52
5 p.
|
artikel
|
| 12 |
Toxicity and side effects of ondansetron
|
Finn, Andrew L.
|
|
1992
|
19 |
4S10 |
p. 53-60
8 p.
|
artikel
|
Tijdschrift beschrijving